Cargando…
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
OBJECTIVE: Distinguishing immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) from the AEs caused by chemotherapy, targeted therapy, or infection is highly difficult. This study offers new insights into evaluating the diagnosis, differential diagnostic, and prognostic...
Autores principales: | Zhang, Weihong, Meng, Yuan, Yang, Lin, Shen, Meng, Zhou, Li, Li, Runmei, Wang, Yang, Du, Weijiao, Xiong, Yanjuan, Han, Ying, Zhang, Xinwei, Liu, Liang, Ren, Xiubao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610162/ https://www.ncbi.nlm.nih.gov/pubmed/34378879 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0037 |
Ejemplares similares
-
Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy: a case report
por: Li, Shuzhan, et al.
Publicado: (2022) -
Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
por: Hui, Zhenzhen, et al.
Publicado: (2015) -
Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023) -
Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma
por: Wang, Yang, et al.
Publicado: (2016) -
Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)